NASDAQ | ETF
The fund will invest primarily in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
Under normal circumstances, the fund invests at least 80% of its assets in the equity securities of healthcare companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 7.34% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.18% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 5.56% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.40% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.12% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.83% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.45% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 3.22% |
| 0QIU | Novo Nordisk A/S Class B | 3.21% | ||
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.00% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.68% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.65% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.39% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.30% |
| ARGX | Argen-X | Healthcare | Biotechnology | 2.24% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.17% |
| MCK | McKesson Corporation | Healthcare | Medical Distribution | 2.07% |
| EL | EssilorLuxottica S. A. | Healthcare | Medical Instruments & Supplies | 2.03% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 1.94% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 1.94% |